elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q41002933-9747B4C8-A762-45D1-B4B9-A2B1B62E593B
Q41002933-9747B4C8-A762-45D1-B4B9-A2B1B62E593B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41002933-9747B4C8-A762-45D1-B4B9-A2B1B62E593B
Detecting similar binding pockets to enable systems polypharmacology.
P2860
Q41002933-9747B4C8-A762-45D1-B4B9-A2B1B62E593B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41002933-9747B4C8-A762-45D1-B4B9-A2B1B62E593B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
714adf6a7294ab3ef6edbead741e6c43b620fcaa
P2860
Life beyond kinases: structure-based discovery of sorafenib as nanomolar antagonist of 5-HT receptors.